Wednesday, 14 April 2021

31% Indians preferring Covishield over Covaxin COVID-19 jabs: GOQii India survey

18 February 2021 | News

23 per cent are still not willing to take either of the vaccines and the remaining 16 per cent are unaware of these vaccines

GOQii India Fit Report 2021 shares interesting insights into the impact of COVID-19 on people’s health and lifestyles, this was gathered through the COVID-19 Impact - The Way Forward survey that was conducted with over 10,000 respondents, spread across India.

79 per cent of the respondents felt that India was effective in curbing COVID-19. Interesting facts revealed that almost 89 per cent of Indians feel that the central government was effective in curbing the COVID-19 pandemic. As for the state and local governments, only 25 per cent and 22 per cent of the respondents respectively, think that they were effective in curbing the spread of COVID-19.

61 per cent of Indians are fine with being administered either Covishield, Covaxin or both. 23 per cent are still not willing to take either of the vaccines and the remaining 16 per cent are unaware of these vaccines. In terms of preference, 31 per cent of Indians prefer taking Covishied while 18 per cent would go with Covaxin, the remaining 51 per cent would be fine with either. 

Speaking about the study, Vishal Gondal, Founder & CEO, GOQii, said, “The GOQii India Fit report sought to understand how the citizens of India felt towards the initiatives taken by the government and the vaccines launched by organisations to curb the pandemic.”

In conclusion, while the COVID-19 inoculation drive is in full swing, Indians have gradually begun easing back into their routines and socialising. The survey findings revealed that eating out at restaurants (27.10 per cent), attending a family function, birthdays (25.95 per cent) and attending weddings (19.54 per cent) are among the top three activities that Indians did in the last three months.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls